Using reported parental disease history to decipher the genetics of Alzheimer’s disease may be promising, but this approach is also susceptible to complex selection and information bias that can mislead researchers if not accounted for. Emil M. Pedersen ...
How a new kind of vaccine could lead to the eradication of Alzheimer’s Features Subscriber-only Health The truth about the new class of Alzheimer’s drugs Insight Subscriber-only Health People with Alzheimer's disease benefit from spending time with horses ...
From Alzheimer's disease to depression to heart disease, Ozempic and other GLP-1 agonist drugs appear to offer a solution. Can one type of drug really tackle so many conditions, and if so, how does it actually work? Features Subscriber-only ...
Alzheimer's disease & dementia Microglia digest large Alzheimer's plaques by spitting enzymes at them, preclinical study finds Immune cells in the brain called microglia can partially break down large amyloid plaques characteristic of Alzheimer's disease by latching on to them, forming a sort of ...
Patient living with early stages of Alzheimer's Disease encouraged by new drug Sury is in a blind study and does not know what medication she's on. She is encouraged by her progress. She's excited to hear about Leqembi and what it could mean. ...
Find all the latest on alzheimer s disease at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.
Discusses Alzheimer's disease in the United States. Stages of the disease; Diagnosis; People susceptible to the disease; Treatment.Chin, Kip LWomen in Business
Novel blood-based biomarker may reliably detect Alzheimer’s-related brain abnormalities Placental growth factor, a blood-based protein, may be a reliable method to detect abnormalities in the brain that presage cognitive impairment indicative of Alzheimer’s disease, data show. ...
FDA: Specific Fast Track Designation for Subcutaneous Formulation of Leqembi for Alzheimer Disease Needed for Rolling Review Erin O'Brien April 4th 2024 This alters the course of developer Eisai's regulatory submission plans for lecanemab in the treatment of early Alzheimer disease. ...
Becoming educated and informed about Alzheimer’s is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes. Get informed Personal experiences It helps to know others have been where you are now. Here’s a collection of our columnis...